Fulcrum Therapeutics
FULC
#6285
Rank
โ‚ฌ0.71 B
Marketcap
10,91ย โ‚ฌ
Share price
-7.25%
Change (1 day)
168.50%
Change (1 year)

Fulcrum Therapeutics (FULC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ14.05 Million

According to Fulcrum Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ14.05 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Fulcrum Therapeutics - Total liabilities on balance sheet (from 2018 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ16.99 M-16.51%
2023-12-31โ‚ฌ20.35 M-21.3%
2022-12-31โ‚ฌ25.86 M24.85%
2021-12-31โ‚ฌ20.71 M-25.92%
2020-12-31โ‚ฌ27.96 M34.53%
2019-12-31โ‚ฌ20.78 M143.37%
2018-12-31โ‚ฌ8.54 M239.57%
2017-12-31โ‚ฌ2.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ20.69 M 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA